Cargando…
Identification of novel first-trimester serum biomarkers for early prediction of preeclampsia
BACKGROUND: Preeclampsia (PE) is a leading cause of maternal and perinatal mortality and morbidity worldwide, but effective early prediction remains a challenge due to the lack of reliable biomarkers. METHODS: Based on the extensive human biobank of our large-scale assisted reproductive cohort platf...
Autores principales: | Liu, Mingxi, Niu, Yue, Ma, Kongyang, Leung, Peter C. K., Chen, Zi-Jiang, Wei, Daimin, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506221/ https://www.ncbi.nlm.nih.gov/pubmed/37718445 http://dx.doi.org/10.1186/s12967-023-04472-1 |
Ejemplares similares
-
Serum estradiol to testosterone ratio as a novel predictor of severe preeclampsia in the first trimester
por: Shen, Yongmei, et al.
Publicado: (2022) -
Evaluation of first trimester maternal serum inhibin-A for preeclampsia screening
por: Moungmaithong, Sakita, et al.
Publicado: (2023) -
Effects of maternal characteristics and medical history on first trimester biomarkers for preeclampsia
por: Torres-Torres, Johnatan, et al.
Publicado: (2023) -
First-Trimester Serum Acylcarnitine Levels to Predict Preeclampsia: A Metabolomics Approach
por: Koster, Maria P. H., et al.
Publicado: (2015) -
Correlation of Maternal Serum Homocysteine in the First Trimester with the Development of Gestational Hypertension and Preeclampsia
por: Sun, Feng, et al.
Publicado: (2017)